h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
CABi001-A
Registration Summary
:
A
P
E
C
PRPF31-MiPS4F3
The cell line was withdrawn.
(only basic data is shown)
General
Cell Line
hPSCreg name
CABi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
CABi001-A (RRID:CVCL_UJ71)
Alternative name(s)
PRPF31-MiPS4F3
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
2nd September 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
CABIMER (Andalusian Molecular Biology and Regenerative Medicine Centre) (CAB)
Contact:
Spanish Stem Cell Bank (ES)
External Databases
Cellosaurus
CVCL_UJ71
General Information
Publications
de la Cerda B et al. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene. Stem cell research. 2019 Apr;36:101426.
(reference publication)
Wheway G et al. Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy. Experimental eye research. 2020 Mar;192:107950.
Jiang Yuxin et al. Alternative Splicing Dysregulation in Retinitis Pigmentosa: Pathogenic Mechanisms and Therapeutic Opportunities. Biomolecules. 2025-11-19.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.